• DE - Deutsch
  • EN - English
Parliamentary question - P-004242/2021Parliamentary question
P-004242/2021

EU Strategy on COVID-19 Therapeutics

Priority question for written answer  P-004242/2021
to the Commission
Rule 138
Moritz Körner (Renew)

The EU Strategy on COVID-19 Therapeutics aims to build a broad portfolio of COVID-19 therapeutics with the goal of having three new therapeutics available by October 2021 and possibly two more by the end of the year. It covers the full lifecycle of medicines from research, development, selection of promising candidates, fast regulatory approval, manufacturing and deployment to final use.

Last updated: 20 September 2021
Legal notice - Privacy policy